Neuroendocrine neoplasms of the GI tract : the role of cytotoxic chemotherapy
Khasraw, Mustafa, Yap, Saw Yee and Ananda, Sumitra 2013, Neuroendocrine neoplasms of the GI tract : the role of cytotoxic chemotherapy, Expert review of anticancer therapy, vol. 13, no. 4, pp. 451-459.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Neuroendocrine neoplasms of the GI tract : the role of cytotoxic chemotherapy
Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of neoplasms derived from peptide- and amine-secreting cells of the neuroendocrine system. NENs commonly arise in the GI tract but can arise in most organs of the body. NENs in different organs share many common pathologic features. Although the incidence of NENs is not high, the prevalence is not low because many patients may live relatively long periods without major symptoms from the disease. While many of these tumors lead an indolent clinical course, they constitute a therapeutic challenge when they progress, metastasize and become symptomatic. Treatment requires a multidisciplinary approach including cytotoxic chemotherapy. Almost all clinical trials investigating cytotoxic chemotherapy in NENs are small single-arm studies and guidelines are derived from expert opinion and from extrapolating results from small cell lung cancer studies. This article briefly reviews NENs before focusing on reviewing data on the role of cytotoxic chemotherapy studies in NENs.
Language
eng
Field of Research
111203 Cancer Genetics
Socio Economic Objective
970111 Expanding Knowledge in the Medical and Health Sciences
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.